SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13G
                                 (Rule 13d-102)

             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
          TO RULES 13d-1 (b) (c), AND (d) AND AMENDMENTS THERETO FILED
                           PURSUANT TO RULE 13d-2 (b)
                                (Amendment No. 1)




                                  Medicure Inc.
--------------------------------------------------------------------------------
                                (Name of Issuer)



                                  Common Stock
--------------------------------------------------------------------------------
                         (Title of Class of Securities)



                                    58469E101
--------------------------------------------------------------------------------


                                 (CUSIP Number)


                                December 31, 2005
--------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)




Check the  appropriate box to designate the rule pursuant to which this Schedule
is filed:


                                [ ] Rule 13d-1(b)
                                [x] Rule 13d-1(c)
                                [ ] Rule 13d-1(d)

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).






(1) NAMES OR REPORTING PERSONS
         S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

         Leeward Hedge Funds Inc.


(2)      CHECK APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
                                        (a) [ ]
                                        (b) [X]

(3) SEC USE ONLY


(4) CITIZENSHIP OR PLACE OF ORGANIZATION

         Ontario, Canada

                                    (5) SOLE VOTING POWER

                                        0

                                    (6) SHARED VOTING POWER
NUMBER OF SHARES                        0
BENEFICIALLY OWNED
BY EACH REPORTING                   (7) SOLE  DISPOSITIVE POWER
PERSON WITH
                                        0

                                    (8) SHARED DISPOSITIVE POWER

                                        0

(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                                        0


(10)     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
         (SEE INSTRUCTIONS)                          [  ]


(11)     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
                                        0%

(12)     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO







Item 1.

         (a) Name of Issuer.

                  Medicure Inc.

         (b) Address of Issuer's Principal Executive Offices.

                  4-1200 Waverly Street
                  Winnipeg, Manitoba, Canada R3T 0P4


Item 2.

         (a) Name of Persons Filing.

                  This Schedule 13G is being filed by Leeward Hedge Funds Inc.
                  ("Leeward").

         (b) Address of Principal Business Office or, if none, Residence.

                  The principal business address of Leeward is:

                  Leeward Hedge Funds Inc.
                  2 Bloor Street West
                  Suite 2100
                  Toronto, Ontario
                  Canada M4W 3E2

         (c) Citizenship.

                  Leeward is an Ontario, Canada corporation.

         (d) Title of Class of Securities.

                  Common Stock

         (e) CUSIP Number.

                  58469E101





Item 3.     If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or
            (c), check whether the person filing is a:

          (a)  [ ] Broker or dealer registered under Section 15 of the Act.

          (b)  [ ] Bank as defined in Section 3(a)(6) of the Act.

          (c)  [ ] Insurance Company as defined in Section 3(a)(19) of the Act.

          (d)  [ ]  Investment  Company  registered  under  Section  8  of  the
               Investment Company Act.

          (e)  [ ]    Investment    Adviser    in    accordance    with   Sec.
               240.13d-1(b)(1)(ii)(E).

          (f)  [ ] Employee  Benefit Plan or Endowment  Fund in accordance  with
               Sec. 240.13d(Y)1(b)(1)(ii)(F).

          (g)  [  ]  Parent   holding   company,   in   accordance   with   Sec.
               240.13d-1(b)(ii)(G).

          (h)  [ ] A savings  association  as  defined  in  Section  3(b) of the
               Federal Deposit Insurance Act.

          (i)  [ ] A church  plan that is  excluded  from the  definition  of an
               investment  company  under  Section  3(c)(14)  of the  Investment
               Company Act of 1940.

          (j)  [ ] Group, in accordance with Sec. 240.13d-1(b)(1)(ii)(J).

         If this statement is filed pursuant to Sec. 240.13d-1(c),
         check this box  [x].



                                                                                    

Item 4.           Ownership

         (a) Amount Beneficially Owned.                                                0

         (b) Percent of Class.                                                         0%

         (c) Number of shares as to which each such person has

                  (i)      sole power to vote or to direct the vote:                   0

                  (ii)     shared power to vote or to direct the vote:                 0

                  (iii)    sole power to dispose or to direct the disposition of:      0

                  (iv)     shared power to dispose or to direct the disposition of:    0





Leeward no longer directly or indirectly owns any shares of Common Stock.





Item 5.           Ownership of Five Percent or Less of a Class.

                  If this statement is being filed to report the fact that as of
                  the date hereof the reporting person has ceased to be the
                  beneficial owner of more than five percent of the class of
                  securities, check the following [ X ].

Item 6.           Ownership of More than Five Percent on Behalf of Another
                  Person.

                  Not applicable.

Item 7.           Identification  and  Classification  of the  Subsidiary  Which
                  Acquired the Security Being Reported on by the Parent
                  Holding Company or Control Person.

                  Not applicable.

Item 8.           Identification and Classification of Members of the Group.

                  Not applicable.


Item 9.           Notice of Dissolution of Group.

                  Not applicable.







Item 10. Certification.

         By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.


                                    SIGNATURE

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Date:  February 14, 2006

                                        Leeward Hedge Funds Inc.


                                        By:  /s/ Brendan Kyne
                                             -----------------------------------
                                        Name:   Brendan Kyne
                                        Title:  Chief Executive Officer



     Attention:  Intentional  misstatements  or  omissions  of  fact  constitute
Federal criminal violations (see 18 U.S.C. 1001).